The MerchantStoreDirectoryAbout UsAdd-siteLink to Us

 

47 Health - Hepatitis Resources

Misc. - A

Antiviral therapies give hepatitis C cirrhosis patients similar life expectancy as general population
The survival rate of patients with hepatitis C virus-related cirrhosis who respond well to antiviral therapies equals that of the general population, say investigators.
May 4, 2016
Read More


Authorities In Detroit Investigating Hepatitis a Cases Linked to Whole Foods
Public health authorities in Detroit are raising the food safety alarm: anyone who bought prepared food at the Whole Foods store at 115 Mack Ave in midtown should seek medical attention, since they may have been exposed to Hepatitis A. While details are fuzzy, they know that the span from Oct. 6-10 is when any exposure would have happened.
October 20, 2016
Read More


Misc. - B

Baby Boomers Get an 'F' for Hep C Testing
Screening rates for the dangerous virus remain low despite recommendations, study finds
March 8, 2017
Read More


Bare metal stents no longer advisable for high bleeding risk ACS patients
A polymer-free, drug-coated stent (DCS) gives markedly better outcomes than a bare metal stent (BMS) in patients with acute coronary syndromes (ACS) and risk factors for bleeding, report researchers.
May 24, 2016
Read More


Blood-born molecules could predict those who will develop liver cancer
A panel of microRNAs from blood samples may predict patients at high risk of developing a common liver cancer from hepatitis B virus infection.
June 5, 2016
Read More


Misc. - C

Consuming Energy Drinks Every day can Cause Hepatitis
Energy drinks are an incredibly popular type of beverage that promises to give you the extra energy you need to get through a busy day. But consuming them can come at the cost of your health, a visit to the doctor, and a diagnosis of hepatitis.
November 2, 2016
Read More


Misc. - D

Discovery of new Hepatitis C Virus mechanism
Researchers have uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions. Using model mice, they confirmed that when a certain enzyme is inhibited, HCV particle production is reduced leading to an improvement of pathological liver conditions. they thereby identified a new drug target for the development of new HCV drugs.
July 27, 2016
Read More


Don't Let Hepatitis C Define You
Hepatitis C doesn't only affect your body. It can be tough on your emotional health, too. you might worry about your future or how others think of you when they learn you have the condition.
November 22, 2016
Read More


Misc. - E

Epclusa drug receives FDA approval for treating adult patients with chronic HCV
The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). for patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin. Epclusa is a fixed-dose combination tablet containing sofosbuvir, a drug approved in 2013, and velpatasvir, a new drug, and is the first to treat all six major forms of HCV.
June 28, 2016
Read More


Experimental drug against hepatitis C slows down Zika virus infection in mice
Virologists have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice.
May 16, 2016
Read More


Misc. - F

FDA grants approval for two drugs to treat hepatitis C virus in children
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.
April 7, 2017
Read More


Misc. - G

Grass pollen allergy vaccine also effective against hepatitis B
A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection, scientists report in a new article.
September 8, 2016
Read More


Misc. - H

Hepatitis B virus screening for Asian American adults can help prevent onset of liver diseases
A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.
May 3, 2016
Read More


Hepatitis C Deaths Hit a Record High
2014 Saw the Highest Number of Hep-C Deaths. Ever.
May 5, 2016
Read More


Hepatitis C mutations 'outrun' immune systems, lab study shows
Study identifies mutations outside of traditional vaccine targets as barrier to vaccine development
March 15, 2017
Read More


Hepatitis C: Once the viral infection has healed, high-risk portal vein hypertension also diminishes
This inflammatory viral infection of the liver causes inflexible scar tissue to form. this in turn impedes blood flow through the organ, with resulting hypertension in the portal vein. Portal hypertension is responsible for most of the lethal complications of liver cirrhosis. a research group has now demonstrated that portal vein hypertension also diminishes once the viral infection is healed. this is a relief for patients, because it means they can stop taking drugs with unpleasant side-effects and they do not need to undergo stressful check-ups quite as frequently.
June 15, 2016
Read More


Hepatitis Infection May Raise Parkinson's Risk
New study adds to evidence that these conditions might be linked somehow
March 30, 2017
Read More


Misc. - I

Investigational dose of oral interferon-free treatment can cure hepatitis C in children
A study that evaluated an investigational dosage of once-daily ledipasvir 45 mg/sofosbuvir 200 mg (LDV/SOF) in children aged six to 11 years infected with HCV, found that 99 percent of children had undetectable levels of HCV-RNA 12 weeks after treatment, report researchers. the study showed that the fixed-dose combination of LDV/SOF was well-tolerated, and no patients experienced serious adverse events related to the study drug.
April 21, 2017
Read More


Misc. - M

Major treatment expansion could essentially eliminate hepatitis C in R.I. by 2030
As the state takes a deep look at its hepatitis C epidemic, researchers have crunched the numbers to project what could be done to lift Rhode Island's burden of death and disease.
August 05, 2016
Read More


Man Develops Severe Hepatitis After Binging on Energy Drinks for Three Weeks
A 50-year-old construction worker who consumed four to five energy drinks a day for three weeks was recently diagnosed with acute hepatitis, a condition characterized by liver inflammation. While not the first case of its kind, the incident points the largely ignored dangers of excess niacin consumption.
November 1, 2016
Read More


Many Canadian territories restrict access to medications for treating hepatitis C, study finds
A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.
October 14, 2016
Read More


Mass incarceration of drug users leads to high levels of HIV, tuberculosis and hepatitis among prisoners
The War on Drugs, mass incarceration of drug users, and the failure to provide proven harm reduction and treatment strategies has led to high levels of HIV, tuberculosis, and hepatitis B and C infection among prisoners–far higher than in the general population.
July 19, 2016
Read More


More than two million people co-infected with HIV, hepatitis C
An estimated 2.3 million people living with HIV are co-infected with hepatitis C virus (HCV) globally, a new study has found. Very little was known about the extent of HIV/HCV coinfection prior to this study, which was the first global study of its kind.
March 8, 2016
Read More


Mother's hepatitis B supports chronic infection in children, study finds
Infection has been cured in mice by removing 'traitors' residing in liver's immune cells
May 3, 2016
Read More


MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV
Hepatitis B is a viral infection that increases the likelihood of developing liver cancer or liver failure. According to the World Health Organization, an estimated 2 billion people currently are infected with HBV, which is more than 10 times the number of people who have human immunodeficiency virus.
September 23, 2016
Read More


Misc. - N

New online learning activity may help GPs manage hepatitis C patients in primary care
A new online learning module, Managing hepatitis C in primary care, provides GPs with an update on the diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.
July 26, 2016
Read More


New research supports hep C treatment for people who use drugs
No treatment, no elimination, say experts
September 7, 2016
Read More


New screen-and-treat programme for hepatitis B may thwart deadly complications of disease
Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.
July 27, 2016
Read More


Newer Hepatitis C Drugs May Pose Health Risks
Newer drugs to cure hepatitis C may put patients at risk for liver failure and other severe side effects, according to a new study from a U.S. nonprofit group that examines drug safety.
January 25, 2017
Read More


Newer medications can cure HCV infections, study suggests
A new analysis reveals a dramatic transformation in the care of patients infected with hepatitis C virus (HCV) as more effective and tolerable medications have become available.
March 8, 2017
Read More


Newer, more effective medications increase number of patients achieving HCV cure
A new analysis reveals a dramatic transformation in the care of patients infected with hepatitis C virus (HCV) as more effective and tolerable medications have become available.
March 8, 2017
Read More


Novel enzyme immunoassay helps diagnose HCV infection in one simple step
The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. now researchers have developed a novel enzyme immunoassay that accomplishes screening and diagnosis in one simple and affordable step.
June 8, 2016
Read More


Misc. - P

Parkinson's risk may be higher with hepatitis virus infection
Individuals infected with hepatitis B or C viruses may have a significantly greater risk of developing Parkinson's disease, new research suggests.
March 30, 2017
Read More


Misc. - R

Research provides insight into molecular mechanisms involved in immune response to HBV
The innate immune system in mammals defends against infection from viruses and other microbial infections. Unfortunately, the human immune response to the hepatitis B virus (HBV) is not yet fully understood. Without vaccination, hepatitis B causes both acute and chronic infections of the liver, and can lead to the development of cirrhosis and liver cancer.
November 28, 2016
Read More


Researchers find easy way to ensure baby boomers get tested for hepatitis C
Baby boomers, adults born between 1945 and 1965, are five times more likely to have been exposed to the hepatitis C virus (HCV).
July 27, 2016
Read More


Researchers identify factors associated with stopping treatment for opioid dependence
Individuals with opioid use disorder who are treated with buprenorphine, a commonly prescribed drug to treat addiction, are more likely to disengage from treatment programs if they are black or Hispanic, unemployed, or have hepatitis C according to a study.
January 5, 2017
Read More


Researchers identify new mechanisms capable of suppressing propagation of HCV
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus (HCV) with the potential of improving pathological liver conditions. Using model mice, they confirmed that when a certain enzyme is inhibited, HCV particle production is reduced leading to an improvement of pathological liver conditions. they thereby identified a new drug target for the development of new HCV drugs.
July 27, 2016
Read More


Misc. - S

'Screen-and-treat' scheme for hepatitis B may prevent deadly complications
Research into Africa's first 'screen-and-treat' program for hepatitis B suggests the initiative may reduce deadly complications of the virus. the hepatitis B virus infects around 250 million people worldwide, and is transmitted through blood and bodily fluids
July 27, 2016
Read More


Serious Infections Tied to Suicide Risk
Danish study finds greater association in those hospitalized with HIV or hepatitis
August 10, 2016
Read More


Solving the hepatitis C epidemic among people with substance abuse disorders
Innovations in HCV treatment at methadone clinics, corrections facilities
April 24, 2017
Read More


Sparing livers: Curing hepatitis C will create transplant opportunities for patients with other illnesses
Recently developed cures for hepatitis C virus will create new opportunities for people with other liver diseases to receive transplanted livers, say researchers.
May 4, 2016
Read More


Spatial epidemiology used to identify 3 key hepatitis C hotspots in Massachusetts
New analysis shows areas with highest rates and counts of hep C infections in Massachusetts
April 27, 2017
Read More


Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis
Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. a Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.
April 24, 2017
Read More


Stop Stress for Help Against Hepatitis C
If you've ever raced against a deadline or mulled a tough decision, you've felt the physical and mental weight of stress. and if you have a long-term condition like hepatitis C? it's part of your everyday life. and you might feel its effects even more when the pressure's on.
November 22, 2016
Read More


Study identifies factors linked to disengagement from treatment for opioid use disorder
Individuals with opioid use disorder who are treated with buprenorphine, a commonly prescribed drug to treat addiction, are more likely to disengage from treatment programs if they are black or Hispanic, unemployed, or have hepatitis C according to a study published online in the Journal of Substance Abuse Treatment.
January 5, 2017
Read More


Misc. - T

Testing for hepatitis C virus remains low among baby boomers
Two years after recommendations, only a small percentage have been tested
March 8, 2017
Read More


Misc. - W

Why baby boomers need a hepatitis C screening
Hepatitis C affects a disproportionate amount of older Americans, born between 1945-1965. a new strategy is helping them get tested.
July 26, 2016
Read More


The MerchantStore © 1997 - 2017